We are live on ! Find out more
ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $3.76B
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
+9.71%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+679.66%
AUM
$13.4B
AUM Growth
+$468M
Cap. Flow
-$459M
Cap. Flow %
-3.43%
Top 10 Hldgs %
22.28%
Holding
376
New
43
Increased
81
Reduced
134
Closed
31

Sector Composition

Rank Sector Weight
1 Healthcare 25.42%
2 Industrials 23.08%
3 Technology 18.58%
4 Consumer Discretionary 13.71%
5 Financials 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEXI
76
DELISTED
NexImmune, Inc. Common Stock
NEXI
$49.5M 0.37%
+103,705
New +$56.4M
VKTX icon
77
Viking Therapeutics
VKTX
$4B
$48.4M 0.36%
7,648,852
-858,938
-10% -$6.04M
FBRX icon
78
Forte Biosciences
FBRX
$1.57B
$47.8M 0.36%
55,783
-61,685
-53% -$50.5M
ECOM
79
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$47.1M 0.35%
1,998,461
-655,324
-25% -$14.5M
FDMT icon
80
4D Molecular Therapeutics
FDMT
$562M
$45.5M 0.34%
1,048,189
-15,555
-1% -$689K
IART icon
81
Integra LifeSciences
IART
$1.34B
$45M 0.34%
651,744
-29,357
-4% -$1.99M
NOMD icon
82
Nomad Foods
NOMD
$1.68B
$43.8M 0.33%
1,593,585
+198,172
+14% +$5.13M
BAC icon
83
Bank of America
BAC
$442B
$43.4M 0.32%
1,122,200
-60,200
-5% -$2.08M
MNTV
84
DELISTED
Momentive Global Inc. Common Stock
MNTV
$42.3M 0.32%
2,310,417
+1,723,799
+294% +$38.8M
ABMD
85
DELISTED
Abiomed Inc
ABMD
$42M 0.31%
131,863
-59,132
-31% -$18.9M
EXAS
86
DELISTED
Exact Sciences
EXAS
$40.7M 0.3%
309,160
-194,673
-39% -$26.6M
NVRO
87
DELISTED
NEVRO CORP.
NVRO
$40.4M 0.3%
289,710
-13,184
-4% -$2.15M
ALLK
88
DELISTED
Allakos
ALLK
$40.4M 0.3%
351,639
+19,267
+6% +$2.43M
PINS icon
89
Pinterest
PINS
$13.4B
$39.6M 0.3%
534,700
-1,418,600
-73% -$106M
ECHO
90
DELISTED
Echo Global Logistics, Inc.
ECHO
$39.5M 0.3%
1,258,699
+37,039
+3% +$1.08M
UIS icon
91
Unisys
UIS
$217M
$37.6M 0.28%
1,478,317
-362,183
-20% -$8.95M
CARG icon
92
CarGurus
CARG
$3.47B
$37.5M 0.28%
1,572,478
+79,711
+5% +$2.31M
ARVN icon
93
Arvinas
ARVN
$572M
$37M 0.28%
559,345
-17,272
-3% -$1.32M
MIME
94
DELISTED
Mimecast Limited
MIME
$36.3M 0.27%
902,883
+562,621
+165% +$24.8M
TBI
95
Trueblue
TBI
$311M
$35.7M 0.27%
1,620,442
-55,371
-3% -$1.14M
CLAR icon
96
Clarus
CLAR
$143M
$34.9M 0.26%
2,049,060
-143,299
-7% -$2.44M
GLD icon
97
SPDR Gold Trust
GLD
$142B
$32M 0.24%
200,000
PARA
98
DELISTED
Paramount Global Class B
PARA
$31.7M 0.24%
+701,800
New +$42.9M
MASI
99
DELISTED
Masimo
MASI
$31.2M 0.23%
136,028
-6,060
-4% -$1.52M
CPS icon
100
Cooper-Standard Automotive
CPS
$558M
$31.2M 0.23%
858,758
-32,305
-4% -$1.21M

Similar funds

ArrowMark Colorado Holdings's Q1 2021 Portfolio in Review

As of Q1 2021, ArrowMark Colorado Holdings held 376 positions worth $13.4B, up 3.6% from $12.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

ArrowMark Colorado Holdings withdrew a net $459M in Q1 2021, closing 31 positions and reducing 134 holdings. Its most notable exit was BioTelemetry, Inc., an estimated $283M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Industrials and Technology.

Against the trend, ArrowMark Colorado Holdings opened a new position in Talis Biomedical Corporation Common Stock worth $77.1M.

  • ArrowMark Colorado Holdings's largest Q1 2021 buy was Talis Biomedical Corporation Common Stock: 400,131 shares worth $77.1M.
  • ArrowMark Colorado Holdings added most to Vroom Inc in Q1 2021, an estimated $65.6M increase.
  • ArrowMark Colorado Holdings's biggest Q1 2021 reduction was Pinterest, cutting an estimated $106M.
  • ArrowMark Colorado Holdings fully exited BioTelemetry, Inc. in Q1 2021, selling an estimated $283M.
  • ArrowMark Colorado Holdings's ten largest holdings make up 22% of its $13.4B portfolio in Q1 2021.
  • ArrowMark Colorado Holdings opened 43 new positions and closed 31 in Q1 2021.
  • ArrowMark Colorado Holdings's portfolio value rose 3.6% quarter-over-quarter to $13.4B.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2021, filed 17 May 2021.